ATE265408T1 - Pulverisiertes mannit und verfahren zu deren herstellung - Google Patents

Pulverisiertes mannit und verfahren zu deren herstellung

Info

Publication number
ATE265408T1
ATE265408T1 AT01400772T AT01400772T ATE265408T1 AT E265408 T1 ATE265408 T1 AT E265408T1 AT 01400772 T AT01400772 T AT 01400772T AT 01400772 T AT01400772 T AT 01400772T AT E265408 T1 ATE265408 T1 AT E265408T1
Authority
AT
Austria
Prior art keywords
production
mum
powdered mannitol
mannitol
pulverulent mannitol
Prior art date
Application number
AT01400772T
Other languages
English (en)
Inventor
Erik Labergerie
Philippe Lefevre
Jose Lis
Original Assignee
Roquette Freres
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0003954A external-priority patent/FR2807034B1/fr
Application filed by Roquette Freres filed Critical Roquette Freres
Application granted granted Critical
Publication of ATE265408T1 publication Critical patent/ATE265408T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C31/00—Saturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C31/18—Polyhydroxylic acyclic alcohols
    • C07C31/26—Hexahydroxylic alcohols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT01400772T 2000-03-29 2001-03-26 Pulverisiertes mannit und verfahren zu deren herstellung ATE265408T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0003954A FR2807034B1 (fr) 2000-03-29 2000-03-29 Mannitol pulverulent et son procede de fabrication

Publications (1)

Publication Number Publication Date
ATE265408T1 true ATE265408T1 (de) 2004-05-15

Family

ID=32241457

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01400772T ATE265408T1 (de) 2000-03-29 2001-03-26 Pulverisiertes mannit und verfahren zu deren herstellung

Country Status (9)

Country Link
US (1) US6743447B2 (de)
KR (1) KR100774047B1 (de)
CN (1) CN1177787C (de)
AT (1) ATE265408T1 (de)
AU (1) AU784886B2 (de)
CA (1) CA2342121C (de)
DE (1) DE60102971T3 (de)
ES (1) ES2218346T5 (de)
MX (1) MXPA01003255A (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6632429B1 (en) * 1999-12-17 2003-10-14 Joan M. Fallon Methods for treating pervasive development disorders
US20070053895A1 (en) 2000-08-14 2007-03-08 Fallon Joan M Method of treating and diagnosing parkinsons disease and related dysautonomic disorders
US8030002B2 (en) 2000-11-16 2011-10-04 Curemark Llc Methods for diagnosing pervasive development disorders, dysautonomia and other neurological conditions
ES2199061B1 (es) * 2002-06-10 2005-02-16 Laboratorios Vita, S.A. Comprimidos bucodispersables y procedimiento para su obtencion.
US20060198838A1 (en) * 2004-09-28 2006-09-07 Fallon Joan M Combination enzyme for cystic fibrosis
WO2007022450A1 (en) * 2005-08-18 2007-02-22 Clean Filtration Technologies, Inc. Hydroclone based fluid filtration system
US20080058282A1 (en) * 2005-08-30 2008-03-06 Fallon Joan M Use of lactulose in the treatment of autism
US20070116695A1 (en) * 2005-09-21 2007-05-24 Fallon Joan M Pharmaceutical preparations for attention deficit disorder, attention deficit hyperactivity disorder and other associated disorders
US9034860B2 (en) * 2006-12-07 2015-05-19 Daiichi Sankyo Company, Limited Pharmaceutical composition containing low-substituted hydroxypropyl cellulose
CA2672134C (en) * 2006-12-07 2015-02-10 Daiichi Sankyo Company, Limited Solid medicinal preparation containing mannitol or lactose
CA2672157C (en) * 2006-12-07 2016-07-26 Daiichi Sankyo Company, Limited Method for producing solid preparation
US8658163B2 (en) 2008-03-13 2014-02-25 Curemark Llc Compositions and use thereof for treating symptoms of preeclampsia
US8084025B2 (en) * 2008-04-18 2011-12-27 Curemark Llc Method for the treatment of the symptoms of drug and alcohol addiction
US9320780B2 (en) * 2008-06-26 2016-04-26 Curemark Llc Methods and compositions for the treatment of symptoms of Williams Syndrome
EP2318035B1 (de) * 2008-07-01 2019-06-12 Curemark, Llc Verfahren und zusammensetzungen zur behandlung von symptomen von neurologischen und geistesstörungen
US10776453B2 (en) * 2008-08-04 2020-09-15 Galenagen, Llc Systems and methods employing remote data gathering and monitoring for diagnosing, staging, and treatment of Parkinsons disease, movement and neurological disorders, and chronic pain
US20100092447A1 (en) 2008-10-03 2010-04-15 Fallon Joan M Methods and compositions for the treatment of symptoms of prion diseases
CA2747611C (en) 2009-01-06 2019-09-17 Curemark Llc Compositions and methods for the treatment or prevention of staphylococcus aureus infections and for the eradication or reduction of staphylococcus aureus on surfaces
WO2010080835A1 (en) 2009-01-06 2010-07-15 Curemark Llc Compositions and methods for the treatment or the prevention oral infections by e. coli
US9056050B2 (en) 2009-04-13 2015-06-16 Curemark Llc Enzyme delivery systems and methods of preparation and use
FR2944971B1 (fr) 2009-04-30 2012-09-07 Roquette Freres Coagglomerats de mannitol et d'amidon granulaire comprimables et a ecoulement libre
FR2949296B1 (fr) * 2009-09-01 2011-11-18 Roquette Freres Procede de remplacement total ou partiel du talc dans les chewing-gums
FR2949462B1 (fr) * 2009-09-01 2011-12-16 Roquette Freres Poudre de cristaux de mannitol define, son procede de fabrication
US9511125B2 (en) 2009-10-21 2016-12-06 Curemark Llc Methods and compositions for the treatment of influenza
JP5976100B2 (ja) 2011-04-21 2016-08-23 キュアマーク リミテッド ライアビリティ カンパニー 神経精神障害の処置のための化合物
US10350278B2 (en) 2012-05-30 2019-07-16 Curemark, Llc Methods of treating Celiac disease
US12226464B2 (en) 2017-04-10 2025-02-18 Curemark, Llc Compositions for treating addiction
CN108553645A (zh) * 2018-03-27 2018-09-21 天津信诚康达药业有限公司 一种创新型辅料蔗糖及其制备方法
US11541009B2 (en) 2020-09-10 2023-01-03 Curemark, Llc Methods of prophylaxis of coronavirus infection and treatment of coronaviruses
CN115671053A (zh) * 2022-11-09 2023-02-03 江西中医药大学 一种含有多孔甘露醇的载药粉末的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3145146A (en) 1961-10-31 1964-08-18 Warner Lambert Pharmaceutical Modified mannitol for pharmaceutical tablets
US3341415A (en) 1964-02-12 1967-09-12 Warner Lambert Pharmaceutical Pharmaceutical tablet excipients of solid particles of a binary solid solution of mannitol with a sugar
FR2571045B1 (fr) 1984-10-03 1987-12-11 Roquette Freres Mannitol granulaire directement compressible et son procede de fabrication
FR2571046B1 (fr) * 1984-10-03 1987-10-16 Roquette Freres Procede de preparation de mannitol granulaire directement compressible
JPS6185330A (ja) 1984-10-04 1986-04-30 Fuji Kagaku Kogyo Kk 直打用賦形薬の製造法
FR2710637B1 (fr) * 1993-09-28 1995-12-08 Roquette Freres Mannitol pulvérulent de friabilité modérée et son procédé de préparation.

Also Published As

Publication number Publication date
CA2342121C (fr) 2010-05-25
ES2218346T3 (es) 2004-11-16
CA2342121A1 (fr) 2001-09-29
KR100774047B1 (ko) 2007-11-06
MXPA01003255A (es) 2004-07-30
CN1177787C (zh) 2004-12-01
KR20010093759A (ko) 2001-10-29
DE60102971D1 (de) 2004-06-03
DE60102971T2 (de) 2005-05-04
US6743447B2 (en) 2004-06-01
DE60102971T3 (de) 2014-04-10
CN1358703A (zh) 2002-07-17
US20030026832A1 (en) 2003-02-06
AU3138201A (en) 2001-10-04
AU784886B2 (en) 2006-07-20
ES2218346T5 (es) 2014-02-27

Similar Documents

Publication Publication Date Title
ATE265408T1 (de) Pulverisiertes mannit und verfahren zu deren herstellung
CA2318128A1 (en) Oral liquid compositions
ATE420630T1 (de) Pulverzubereitungen und verfahren zu ihrer herstellung
IL160797A0 (en) ORAL PHARMACEUTICAL PRODUCTS CONTAINING 17beta-ESTRADIOL-3-LOWER ALKANOATE, METHOD OF ADMINISTERING THE SAME AND PROCESS OF PREPARATION
EE200200151A (et) Osake, ravimvorm, nende valmistamismeetodid, osakeste kasutamine ning farmatseutiline pakend
IL150225A0 (en) Lipopeptides, pharmaceutical compositions containing the same and methods for the production thereof
IL89503A0 (en) Taxol derivatives,pharmaceutical compositions containing the same and process for the preparation thereof
GB0100758D0 (en) Immunogenic complex method of preparation thereof and pharmaceutical compositions containing the same, useful for disease control
CY1115707T1 (el) Στερεα σταθεροποιημενα θεραπευτικα συστηματα ταχειας και/ή τροποποιημενης απελευθερωσης για τη χορηγηση απο του στοματος υγρων δραστικων ουσιων, εκδοχων ή τροφιμων
HUP0301315A3 (en) Benzothiazole derivatives, process for their preparation, their use and pharmaceutical compositions containing them
HUP0303078A3 (en) Cyclic peptidies process for their preparation pharmaceutical compositions containing them and their use
HUP0303391A3 (en) Aliphatic nitrogenous five-membered ring compounds, process for their preparation, pharmaceutical compositions containing them and their use
GB9808802D0 (en) Pharmaceutical formulations
ES2184523T3 (es) Procedimientos para obtener una composicion detergente granular que tiene un aspecto y solubilidad mejoradas.
DE50203302D1 (de) Verfahren zur herstellung von direkt tablettierbarem alpha-mannit
IL150528A0 (en) Ibuprofen containing active agent preparation
ZA200208761B (en) Pharmaceutical form of administration for peptides, methods for its production and use.
DE60022890D1 (de) Naphthyridine derivate, verfahren zu ihrer herstellung, deren anwendung und sie enthaltende pharmazeutische zusammensetzungen
AP2004003045A0 (en) Preparation compositions containing acid-unstable physiologically active compounds and process for producing the same.
IL152074A0 (en) Pharmaceutical preparations and their manufacture
DE69934781D1 (de) Morphinsulfat enthaltende mikrogranulate, verfahren zu deren herstellung und pharmazeutische zusammensetzungen
HUP0300221A3 (en) Use of oltipraz as an antifibrotic and anticirrhotic agent in the liver for producing pharmaceutical compositions and pharmaceutical compositions containing oltipraz and process for producing them
DE60033519D1 (de) Morphinsulfat enthaltende mikrogranulate, verfahren zu deren herstellung und pharmazeutische zusammensetzungen
ATE424186T1 (de) Medizinische aerosolzusammensetzungen mit einem funktionalisierten polyethylenglykol-hilfsstoff
HUP0301116A3 (en) Novel form of (r)-n-[5-methyl-8-(4-methylpiperazin-1-yl)-1,2,3,4-tetrahydro-2-naphthyl]-4-morpholinobenzamide, process for its preparation and pharmaceutical composition containing it

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties